Nephrogenic Systemic Fibrosis: Evidence for Oxidative Stress and Bone Marrow-derived Fibrocytes in Skin, Liver, and Heart Lesions Using a 5/6 Nephrectomy Rodent Model
Overview
Authors
Affiliations
Nephrogenic systemic fibrosis (NSF) is associated with gadolinium-based magnetic resonance imaging (MRI) contrast exposure in the setting of acute or chronic renal compromise. It has been proposed that circulating fibrocytes mediate the disease. A study was conducted to determine whether bone marrow-derived fibroblast precursors are involved in contributing to organ fibrosis in MRI contrast-treated rodents with renal insufficiency. Rats status post 5/6 nephrectomy underwent bone marrow transplant from human placental alkaline phosphatase (hPAP)-expressing donors. After engraftment, animals were treated with gadolinium-based MRI contrast (2.5 mmol/kg IP), during weekdays for 4 weeks, or an equivalent volume of normal saline. Dermal cellularity in the contrast-treated group was fourfold that of control. Skin cells from the contrast-treated group demonstrated greater hPAP expression with co-expression of pro-collagen I and α-smooth muscle actin-positive stress fibers. Donor and host cells expressed CD34. Dihydroethidium staining of skin was greater in the contrast-treated animals, indicating oxidative stress. This was abrogated when the animals were co-administered the superoxide dismutase mimetic tempol. In conclusion, a bone marrow-derived cell population is increased in the dermis of MRI contrast-treated rodents. The cell markers are consistent with fibrocytes mediating the disease. These changes correlate with oxidative stress and expression of Nox4, suggestive of a novel therapeutic target. Elucidation of the mechanisms of MRI contrast-induced fibrosis may aid in discovering therapies to this devastating disease.
The safety of magnetic resonance imaging contrast agents.
Cunningham A, Kirk M, Hong E, Yang J, Howard T, Brearley A Front Toxicol. 2024; 6:1376587.
PMID: 39188505 PMC: 11345262. DOI: 10.3389/ftox.2024.1376587.
Toxicity Mechanisms of Gadolinium and Gadolinium-Based Contrast Agents-A Review.
Coimbra S, Rocha S, Sousa N, Catarino C, Belo L, Bronze-da-Rocha E Int J Mol Sci. 2024; 25(7).
PMID: 38612881 PMC: 11012457. DOI: 10.3390/ijms25074071.
DeAguero J, Howard T, Kusewitt D, Brearley A, Ali A, Degnan J Sci Rep. 2023; 13(1):2025.
PMID: 36739294 PMC: 9899216. DOI: 10.1038/s41598-023-28666-1.
Jackson D, MacIntyre T, Duarte-Miramontes V, DeAguero J, Escobar G, Wagner B Fed Pract. 2022; 39(5):218-225.
PMID: 35935925 PMC: 9351733. DOI: 10.12788/fp.0258.
Therapeutic Implications of Ferroptosis in Renal Fibrosis.
Zhang Y, Mou Y, Zhang J, Suo C, Zhou H, Gu M Front Mol Biosci. 2022; 9:890766.
PMID: 35655759 PMC: 9152458. DOI: 10.3389/fmolb.2022.890766.